International Stem Cell CORP (ISCO) stock
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
International Stem Cell cash
Cash and short-term investments held at the end of each period.
International Stem Cell's cash was $1.09M at Jun 30, 2026. For fiscal 2025 it was $993.00K, down 19.3% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $5.78M in fiscal 2010.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $993.00K | -19.3% |
| FY2024 | Dec 31, 2024 | $1.23M | -22.5% |
| FY2023 | Dec 31, 2023 | $1.59M | +114.0% |
| FY2022 | Dec 31, 2022 | $742.00K | +333.9% |
| FY2021 | Dec 31, 2021 | $171.00K | -75.2% |
| FY2020 | Dec 31, 2020 | $689.00K | +42.4% |
| FY2019 | Dec 31, 2019 | $484.00K | -55.0% |
| FY2018 | Dec 31, 2018 | $1.08M | +253.6% |
| FY2017 | Dec 31, 2017 | $304.00K | +176.4% |
| FY2016 | Dec 31, 2016 | $110.00K | -79.3% |
| FY2015 | Dec 31, 2015 | $532.00K | -52.1% |
| FY2014 | Dec 31, 2014 | $1.11M | -50.5% |
| FY2013 | Dec 31, 2013 | $2.24M | +243.0% |
| FY2012 | Dec 31, 2012 | $654.00K | -51.1% |
| FY2011 | Dec 31, 2011 | $1.34M | -76.9% |
| FY2010 | Dec 31, 2010 | $5.78M | +695.3% |
| FY2009 | Dec 31, 2009 | $727.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.09M | +18.4% |
| Q1 FY2026 | Mar 31, 2026 | $933.00K | -35.7% |
| Q4 FY2025 | Dec 31, 2025 | $993.00K | -19.3% |
| Q3 FY2025 | Sep 30, 2025 | $966.00K | -26.1% |
| Q2 FY2025 | Jun 30, 2025 | $920.00K | -28.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.45M | +4.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.23M | -22.5% |
| Q3 FY2024 | Sep 30, 2024 | $1.31M | -8.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.29M | -6.7% |
| Q1 FY2024 | Mar 31, 2024 | $1.39M | +47.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.59M | +114.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.43M | +114.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.38M | +135.8% |
| Q1 FY2023 | Mar 31, 2023 | $943.00K | +136.9% |
| Q4 FY2022 | Dec 31, 2022 | $742.00K | +333.9% |
| Q3 FY2022 | Sep 30, 2022 | $666.00K | -11.2% |
| Q2 FY2022 | Jun 30, 2022 | $586.00K | -47.5% |
| Q1 FY2022 | Mar 31, 2022 | $398.00K | -42.2% |
| Q4 FY2021 | Dec 31, 2021 | $171.00K | -83.3% |
| Q2 FY2021 | Jun 30, 2021 | $750.00K | -43.0% |
| Q1 FY2021 | Mar 31, 2021 | $1.12M | +57.8% |
| Q4 FY2020 | Dec 31, 2020 | $689.00K | +42.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.03M | +121.6% |
| Q2 FY2020 | Jun 30, 2020 | $1.32M | +121.0% |
| Q1 FY2020 | Mar 31, 2020 | $708.00K | +15.1% |
| Q4 FY2019 | Dec 31, 2019 | $484.00K | -55.0% |
| Q3 FY2019 | Sep 30, 2019 | $463.00K | -60.1% |
| Q2 FY2019 | Jun 30, 2019 | $595.00K | +24.7% |
| Q1 FY2019 | Mar 31, 2019 | $615.00K | +37.6% |
| Q4 FY2018 | Dec 31, 2018 | $1.08M | +253.6% |
| Q3 FY2018 | Sep 30, 2018 | $1.16M | +127.6% |
| Q2 FY2018 | Jun 30, 2018 | $477.00K | +60.6% |
| Q1 FY2018 | Mar 31, 2018 | $447.00K | -33.9% |
| Q4 FY2017 | Dec 31, 2017 | $304.00K | +176.4% |
| Q3 FY2017 | Sep 30, 2017 | $510.00K | -30.4% |
| Q2 FY2017 | Jun 30, 2017 | $297.00K | -59.5% |
| Q1 FY2017 | Mar 31, 2017 | $676.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $110.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $733.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $733.00K | – |
See a number that looks wrong?